OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
Dongming Jiang, Li-juan Zhang, Wenbin Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 10, pp. 1024-1036
Open Access | Times Cited: 71
Dongming Jiang, Li-juan Zhang, Wenbin Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 10, pp. 1024-1036
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
The global burden of lung cancer: current status and future trends
Amanda Leiter, Rajwanth Veluswamy, Juan P. Wisnivesky
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 624-639
Closed Access | Times Cited: 565
Amanda Leiter, Rajwanth Veluswamy, Juan P. Wisnivesky
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 624-639
Closed Access | Times Cited: 565
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 78
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 78
Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study
Jiansheng Lin, Hongwei Zhang, Hongping Yu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 54
Jiansheng Lin, Hongwei Zhang, Hongping Yu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 54
Structure-activity of chlormethine fluorescent prodrugs: Witnessing the development of trackable drug delivery
Wenfang Jin, Baolei Fan, Xinrui Qin, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 214999-214999
Open Access | Times Cited: 26
Wenfang Jin, Baolei Fan, Xinrui Qin, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 214999-214999
Open Access | Times Cited: 26
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
Linfeng Xian, Pei Zhao, Xi Chen, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 1019-1036
Closed Access | Times Cited: 37
Linfeng Xian, Pei Zhao, Xi Chen, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 1019-1036
Closed Access | Times Cited: 37
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 18
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 18
Plant extracellular vesicles: A novel bioactive nanoparticle for tumor therapy
Zhao-Lin Tan, Jing-Fei Li, Haoming Luo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Zhao-Lin Tan, Jing-Fei Li, Haoming Luo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study
Ruirui Song, Yanfen Cui, Jialiang Ren, et al.
Radiotherapy and Oncology (2022) Vol. 171, pp. 155-163
Closed Access | Times Cited: 21
Ruirui Song, Yanfen Cui, Jialiang Ren, et al.
Radiotherapy and Oncology (2022) Vol. 171, pp. 155-163
Closed Access | Times Cited: 21
Trace elements in pancreatic cancer
Yao Yanjun, Zhuang Jing, Song Yifei, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 4
Yao Yanjun, Zhuang Jing, Song Yifei, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 4
Trends of cause-specific cardiovascular disease mortality in China, 2009-2019: a nationwide longitudinal study
Lu Wang, Yuzhu Wang, Zixiang Ji, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Lu Wang, Yuzhu Wang, Zixiang Ji, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Analysis of trends in cancer mortality and the years of life lost in six provinces in northwest China from 2013 to 2021
Hao Bi, Ning Wang, Yong Xia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hao Bi, Ning Wang, Yong Xia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
TNMpBC-NeoBCSS model: a breast cancer specific survival prediction model for triple-negative metaplastic breast carcinoma patients with neoadjuvant therapy
Peng Ni, Yu Wang, Xiaorong Bai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Peng Ni, Yu Wang, Xiaorong Bai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Prediction of potential targets of aloe-emodin in the treatment of hepatocellular carcinoma using network pharmacology combined with bioinformatics
Jianfeng Wei, Haosong Chen, Maoqi Xu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Jianfeng Wei, Haosong Chen, Maoqi Xu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Patents on the move: The therapeutic future of liquid crystals in cancer
Silvia Vitória Silva Cézar, Alcimary Bispo Santos, Anamaria Mendonça Santos, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105822-105822
Closed Access | Times Cited: 3
Silvia Vitória Silva Cézar, Alcimary Bispo Santos, Anamaria Mendonça Santos, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105822-105822
Closed Access | Times Cited: 3
Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: An analysis and comparison
Mimi Wang, Huiwen Miao
Tobacco Induced Diseases (2024) Vol. 22, Iss. August, pp. 1-11
Open Access | Times Cited: 3
Mimi Wang, Huiwen Miao
Tobacco Induced Diseases (2024) Vol. 22, Iss. August, pp. 1-11
Open Access | Times Cited: 3
The Insulin-like Growth Factor System and Colorectal Cancer
Nikola Gligorijević, Zorana Dobrijević, Miloš Šunderić, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1274-1274
Open Access | Times Cited: 14
Nikola Gligorijević, Zorana Dobrijević, Miloš Šunderić, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1274-1274
Open Access | Times Cited: 14
Esophagus cancer and essential trace elements
Xin Yang, Zhe Tang, Jing Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 14
Xin Yang, Zhe Tang, Jing Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 14
Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2 ‐low and HER2 ‐zero breast cancer among Chinese females
Lu Zheng, Yunmeng Zhang, Zhipeng Wang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 14, pp. 14937-14948
Open Access | Times Cited: 8
Lu Zheng, Yunmeng Zhang, Zhipeng Wang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 14, pp. 14937-14948
Open Access | Times Cited: 8
Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC
Ting Li, Jiang Guo, Yushen Liu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2137-2149
Open Access | Times Cited: 7
Ting Li, Jiang Guo, Yushen Liu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2137-2149
Open Access | Times Cited: 7
Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
Hao Luo, Chongming Huang, Meng Meng, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Hao Luo, Chongming Huang, Meng Meng, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Current status of short video as a source of information on lung cancer: a cross-sectional content analysis study
Xinyu Zhao, Xingxing Yao, Binbin Sui, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Xinyu Zhao, Xingxing Yao, Binbin Sui, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC–MS/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy
Ying Jin, Chaoqun He, Xiangjie Di, et al.
Journal of Chromatography B (2022) Vol. 1207, pp. 123362-123362
Closed Access | Times Cited: 11
Ying Jin, Chaoqun He, Xiangjie Di, et al.
Journal of Chromatography B (2022) Vol. 1207, pp. 123362-123362
Closed Access | Times Cited: 11
A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society
Jibin Li, Zhuochen Lin, Martin C. S. Wong, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Jibin Li, Zhuochen Lin, Martin C. S. Wong, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11
